Michigan Initial Experience Using Tigertriever for Thrombectomy
Henry Ford Health System
150 participants
Jan 15, 2026
OBSERVATIONAL
Conditions
Summary
The purpose of this research study is to collect data about the effectiveness (i.e. how the device works) and safety (how safe it is to use such a device) of the Tigertriever in restoring blood flow by removing thrombus (or blood clot) from a large intracranial vessel (blood vessel in the brain) in patients experiencing ischemic stroke within 8 hours of symptom onset.
Eligibility
Inclusion Criteria4
- Patients admitted with large vessel occlusion (LVO) and treated with the Tigertriever, as per the approved indication.
- Tigertriever was used as the first line treatment in the target vessel.
- A signed informed consent.
- Age ≥ 18.
Exclusion Criteria2
- Evidence of acute brain hemorrhage on NCCT or MR at admission. 2. Prior hemorrhage, stroke, thrombolysis, and/or endovascular therapy in the last 3 months.
- \. pre-stroke disability (pre-stroke mRS ≥ 2).
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
You will be asked to provide medical history, take neurological exams in the form of questionnaires, and provide imaging data.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07363525